Even mild dehydration affects your body significantly. Drinking less than 500 ml daily strains kidneys, reduces brain ...

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at American Society of Nephrology Kidney Week 2025 November 5–9.

Chronic Kidney Disease (CKD) is quietly rising as a global health crisis, and the latest research reveals just how serious the situation has become. A landmark global analysis published in The Lancet ...

Balcinrenone is similar to finerenone (Kerendia), which is also a nonsteroidal MRA and was approved for the slowing of ...

Adverse changes in the heart’s structure and function are common in people with chronic kidney disease (CKD), warranting mitigating therapies.

Diabetes Philippines is urging the public to get tested for diabetes immediately. Doctors warn that most people are diagnosed too late, only after severe complications such as kidney disease, heart ...

The benefits of SGLT2 inhibitors on kidney disease progression in individuals irrespective of diabetes or albuminuria status ...

Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from ...

Kidney disease disproportionately affects Black communities, with Black Americans nearly four times as likely to develop ...

One-year program includes diet, exercise, stress relief, and physician consultations. Glycemic control and other markers ...

Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per 100,000 person-years. It is characterized by severe proteinuria and ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...